Key statistics
On Wednesday, Organon & Co (OGN:NYQ) closed at 19.97, -13.55% below its 52-week high of 23.10, set on Aug 26, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 20.51 |
---|---|
High | 20.58 |
Low | 19.42 |
Bid | 19.90 |
Offer | 20.62 |
Previous close | 20.55 |
Average volume | 1.55m |
---|---|
Shares outstanding | 257.47m |
Free float | 257.05m |
P/E (TTM) | 5.29 |
Market cap | 5.29bn USD |
EPS (TTM) | 3.89 USD |
Annual div (ADY) | 1.12 USD |
---|---|
Annual div yield (ADY) | 5.45% |
Div ex-date | Aug 16 2024 |
Div pay-date | Sep 12 2024 |
Data delayed at least 15 minutes, as of Sep 19 2024 00:00 BST.
More ▼
- Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%
- Organon & Lilly Expand Migraine Commercialization Agreement to 11 Additional Markets
- Organon Reports Results for the Second Quarter Ended June 30, 2024
- Organon To Report Second Quarter 2024 Results and Host Conference Call on August 6, 2024